Diversity ofCNCM I-745 mechanisms of action against intestinal infections.
World J Gastroenterol. 2019 May 14 ;25(18):2188-2203. PMID: 31143070
The yeastCNCM I-745 is one of the probiotics recommended for the prevention of antibiotic-associated diarrhea. Studies conductedanddemonstrated that in the case of infectious diseases there are two potential sites of action ofCNCM I-745: (1) An action on enteropathogenic microorganisms (adhesion of bacteria and their elimination or an effect on their virulence factors: Toxins, lipopolysaccharide,.); and (2) a direct action on the intestinal mucosa (trophic effects, effects on epithelial reconstitution, anti-secretory effects, anti-inflammatory, immunomodulators). Oral administration ofCNCM I-745 to healthy subjects does not alter their microbiota. However, in the case of diseases associated with the use of antibiotics or chronic diarrhea,CNCM I-745 can restore the intestinal microbiota faster. The interaction ofCNCM I-745 with the innate immune system have been recently demonstrated thus opening up a new therapeutic potential of this yeast in the case of diseases associated with intestinal infections but also other pathologies associated with dysbiosis such as inflammatory diseases.